Skip to main content
. 2009 Mar;94(3):364–371. doi: 10.3324/haematol.13862

Figure 1.

Figure 1.

(A) Overall survival and (B) time to first therapy in the 350 patients with B-CLL. (C) Overall survival of patients with ≥80% or <80% cells showing the 13q14 deletion against that of patients in the other cytogenetic groups. The median survival and median time to first therapy is shown in months for each cytogenetic group.